alexa Hematologic Adverse Effects following Systemic Chemothe

Journal of Oncology Medicine & Practice
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

Hematologic Adverse Effects following Systemic Chemotherapy

Shahrasbi A*, Armin A, Ardebili A, Rafie KS, Ansari M and Rabani M

Hematology-Oncology Section, Booali Hospital, Tehran Medical Branch, Islamic Azad University, Tehran, Iran

*Corresponding Author:
Shahrasbi A
Hematology-Oncology Section, Booali Hospital
Tehran Medical Branch, Azad University, Tehran, Iran
Tel: 00989121309264
Email: [email protected]

Received date: May 28, 2017; Accepted date: June 20, 2017; Published date: June 24, 2017

Citation: Shahrasbi A, Armin A, Ardebili A, Rafie KS, Ansari M, et al. (2017) Hematologic Adverse Effects following Systemic Chemotherapy. J Oncol Med & Pract 2:110.

Copyright: © 2017 Shahrasbi A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.



Introduction: Cytopenia is one of the most important side effects of chemotherapy. It presents as pancytopenia or bicytopenia or monocytopenia. Cytopenia is a challenging factor for delivering chemotherapy drugs. Methods: In this study we were looking for the incidence of cytopenia in patients received chemotherapy in two different hospitals. Results: 200 patients were included in our study. Most of the patients were female and anemia was the most adverse effect which was followed by leukopenia and thrombocytopenia. Bicytopenia and pancytopenia were the least side effects of chemotherapy drugs. Conclusion: Although our study was not a head to head one anemia was the most adverse effect following systemic chemotherapy in both hospitals. Overall cytopenia was more prevalent in the university hospital than private hospital. This difference was significant for anemia (P-value ≤ 0.05) but it wasn’t for leukopenia or thrombocytopenia. Bicytopenia and pancytopenia happened very rarely.


Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version